Guide pratique sur le MAP

↪ Fondation canadienne pour la santé vasculaire 28 18. Villemur B, Marquer A, Gailledrat E, Benetreau C, Bucci B, Evra V, Rabeau V, De Angelis M-P, Bouchet J-Y, Carpentier P, Perennou D. New rehabilitation program for intermittent claudication: Interval training with active recovery: pilot study. Ann Phys Rehabil Med 54: 275–281, 2011. 19. Zwierska I, Walker RD, Choksy SA, Male JS, Pockley AG, Saxton JM. Upper- vs lower-limb aerobic exercise rehabilitation in patients with symptomatic peripheral arterial disease: a randomized controlled trial. J Vasc Surg 42: 1122–1130, 2005. 20. Zwierska I, Walker RD, Choksy SA, Male JS, Pockley AG, Saxton JM. Relative tolerance to upper- and lower-limb aerobic exercise in patients with peripheral arterial disease. Eur J Vasc Endovasc Surg 31: 157–163, 2006. Section 8 1. McDermott MM. Lower extremity manifestations of peripheral artery disease: the pathophysiologic and functional implications of leg ischemia. Circ Res. 2015;116:1540-50. 2. Lauret GJ, Fakhry F, Fokkenrood HJ, Hunink MG, Teijink JA and Spronk S. Modes of exercise training for intermittent claudication. Cochrane Database Syst Rev. 2014:CD009638. 3. Gerhard-Herman MD, Gornik HL, Barrett C, Barshes NR, Corriere MA, Drachman DE, Fleisher LA, Fowkes FG, Hamburg NM, Kinlay S, Lookstein R, Misra S, Mureebe L, Olin JW, Patel RA, Regensteiner JG, Schanzer A, Shishehbor MH, Stewart KJ, Treat-Jacobson D and Walsh ME. 2016 AHA/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol . 2017;69:1465-1508. 4. Gardner AW, Parker DE, Montgomery PS, Scott KJ and Blevins SM. Ef cacy of quanti ed home-based exercise and supervised exercise in patients with intermittent claudication: a randomized controlled trial. Circulation . 2011;123:491-8. 5. Sanderson B, Askew C, Stewart I, Walker P, Gibbs H and Green S. Short-term effects of cycle and treadmill training on exercise tolerance in peripheral arterial disease. J Vasc Surg . 2006;44:119-27. 6. Zwierska I, Walker RD, Choksy SA, Male JS, Pockley AG and Saxton JM. Upper- vs lower-limb aerobic exercise rehabilitation in patients with symptomatic peripheral arterial disease: a randomized controlled trial. J Vasc Surg . 2005;42:1122-30. 7. Mankowski RT, Anton SD, Axtell R, Chen SH, Fielding RA, Glynn NW, Hsu FC, King AC, Layne AS, Leeuwenburgh C, Manini TM, Marsh AP, Pahor M, Tudor-Locke C, Conroy DE, Buford TW and Group LR. Device-Measured Physical Activity As a Predictor of Disability in Mobility-Limited Older Adults. J Am Geriatr Soc . 2017;65:2251- 2256. 8. McDermott MM, Spring B and Treat-Jacobson D. Use of a Wearable Activity Monitor in a Home-Based Exercise Intervention for Peripheral Artery Disease-Reply. JAMA . 2018;320:1286. 9. Gal R, May AM, van Overmeeren EJ, Simons M and Monninkhof EM. The Effect of Physical Activity Interventions Comprising Wearables and Smartphone Applications on Physical Activity: a Systematic Review and Meta-analysis. Sports Med Open . 2018;4:42. 10. Xie J, Wen D, Liang L, Jia Y, Gao L and Lei J. Evaluating the Validity of Current Mainstream Wearable Devices in Fitness Tracking Under Various Physical Activities: Comparative Study. JMIR Mhealth Uhealth . 2018;6:e94.